Direct Biologics Receives FDA Approval to Initiate ‘EXIT-COVID-19,’ a Phase II Investigational New Drug Trial
Direct Biologics Receives FDA Approval to Initiate ‘EXIT-COVID-19,’ a Phase II Investigational New Drug Trial AUSTIN, Texas, July 29, 2020 (Newswire.com) Direct Biologics, LLC, is… Read More »Direct Biologics Receives FDA Approval to Initiate ‘EXIT-COVID-19,’ a Phase II Investigational New Drug Trial